QQQ   322.48 (+2.65%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
QQQ   322.48 (+2.65%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
QQQ   322.48 (+2.65%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
QQQ   322.48 (+2.65%)
AAPL   126.26 (+4.12%)
MSFT   236.96 (+1.97%)
FB   260.88 (+1.27%)
GOOGL   2,059.48 (+1.86%)
TSLA   712.20 (+5.43%)
AMZN   3,126.50 (+1.09%)
NVDA   548.85 (+0.05%)
BABA   239.88 (+0.89%)
CGC   34.64 (+5.77%)
GE   13.23 (+5.50%)
MU   94.54 (+3.29%)
NIO   49.53 (+8.19%)
AMD   85.62 (+1.31%)
T   28.30 (+1.47%)
F   12.00 (+2.56%)
ACB   11.15 (+5.99%)
DIS   194.75 (+3.02%)
BA   223.86 (+5.59%)
NFLX   551.75 (+2.39%)
BAC   35.54 (+2.39%)
Log in
NASDAQ:GBT

Global Blood Therapeutics News Headlines

$43.63
+1.03 (+2.42 %)
(As of 03/1/2021 12:01 PM ET)
Add
Compare
Today's Range
$43.45
Now: $43.63
$44.73
50-Day Range
$43.50
MA: $48.84
$50.85
52-Week Range
$36.49
Now: $43.63
$83.69
Volume8,956 shs
Average Volume1.11 million shs
Market Capitalization$2.70 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.39

Headlines

Global Blood Therapeutics (NASDAQ GBT) News Headlines Today

Source:
SourceHeadline
Global Blood Therapeutics (NASDAQ:GBT) Cut to Market Perform at William BlairGlobal Blood Therapeutics (NASDAQ:GBT) Cut to Market Perform at William Blair
marketbeat.com - February 25 at 8:46 AM
Q1 2021 Earnings Estimate for Global Blood Therapeutics, Inc. (NASDAQ:GBT) Issued By William BlairQ1 2021 Earnings Estimate for Global Blood Therapeutics, Inc. (NASDAQ:GBT) Issued By William Blair
americanbankingnews.com - March 1 at 2:28 AM
Research Analysts Set Expectations for Global Blood Therapeutics, Inc.s Q1 2021 Earnings (NASDAQ:GBT)Research Analysts Set Expectations for Global Blood Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:GBT)
americanbankingnews.com - March 1 at 2:28 AM
Truist Securiti Comments on Global Blood Therapeutics, Inc.s Q1 2021 Earnings (NASDAQ:GBT)Truist Securiti Comments on Global Blood Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:GBT)
americanbankingnews.com - March 1 at 1:56 AM
Global Blood (GBT) Q4 Earnings Miss, Revenues Beat EstimatesGlobal Blood (GBT) Q4 Earnings Miss, Revenues Beat Estimates
nasdaq.com - February 25 at 3:56 PM
Global Blood Therapeutics (NASDAQ:GBT) Announces Quarterly  Earnings Results, Misses Expectations By $0.03 EPSGlobal Blood Therapeutics (NASDAQ:GBT) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS
americanbankingnews.com - February 25 at 2:04 PM
William Blair Lowers Global Blood Therapeutics (NASDAQ:GBT) to Market PerformWilliam Blair Lowers Global Blood Therapeutics (NASDAQ:GBT) to Market Perform
americanbankingnews.com - February 25 at 9:37 AM
Recap: Global Blood Therapeutics Q4 EarningsRecap: Global Blood Therapeutics Q4 Earnings
finance.yahoo.com - February 25 at 12:11 AM
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial ResultsGBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 7:11 PM
Preview: Global Blood Therapeuticss EarningsPreview: Global Blood Therapeutics's Earnings
finance.yahoo.com - February 23 at 2:21 PM
Global Blood Therapeutics (GBT) Set to Announce Earnings on WednesdayGlobal Blood Therapeutics (GBT) Set to Announce Earnings on Wednesday
americanbankingnews.com - February 18 at 9:27 AM
GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
finance.yahoo.com - February 17 at 12:00 PM
Is Global Blood Therapeutics (NASDAQ:GBT) A Risky Investment?Is Global Blood Therapeutics (NASDAQ:GBT) A Risky Investment?
finance.yahoo.com - February 8 at 9:08 AM
GBT Initiates Expanded Access Protocol for Oxbryta(R) (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United StatesGBT Initiates Expanded Access Protocol for Oxbryta(R) (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
marketwatch.com - February 5 at 9:57 AM
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United StatesGBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
finance.yahoo.com - February 4 at 1:08 PM
Global Blood Therapeutics, Inc.: European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) forGlobal Blood Therapeutics, Inc.: European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for
bloomberg.com - January 28 at 7:45 PM
European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell DiseaseEuropean Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
finance.yahoo.com - January 27 at 7:25 AM
GBT Announces Participation at the 39th Annual J.P. Morgan Healthcare ConferenceGBT Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:43 AM
Loss-Making Global Blood Therapeutics, Inc. (NASDAQ:GBT) Expected To Breakeven In The Medium-TermLoss-Making Global Blood Therapeutics, Inc. (NASDAQ:GBT) Expected To Breakeven In The Medium-Term
finance.yahoo.com - December 25 at 12:25 PM
Global Blood Therapeutics: More Growth For InclacumabGlobal Blood Therapeutics: More Growth For Inclacumab
seekingalpha.com - December 14 at 3:38 PM
Global Blood Therapeutics Inc.Global Blood Therapeutics Inc.
barrons.com - December 10 at 12:02 AM
GBT Appoints Kim Smith-Whitley, M.D., to Lead Research and DevelopmentGBT Appoints Kim Smith-Whitley, M.D., to Lead Research and Development
finance.yahoo.com - December 7 at 8:32 AM
GBT Presents New Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor) Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual Meeting and ExpositionGBT Presents New Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor) Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - December 6 at 4:39 PM
Why Is Global Blood (GBT) Down 27.3% Since Last Earnings Report?Why Is Global Blood (GBT) Down 27.3% Since Last Earnings Report?
finance.yahoo.com - December 5 at 5:48 PM
GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United StatesGBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States
finance.yahoo.com - December 2 at 7:46 AM
Global Blood Therapeutics: 40% Discount On A Billion-Dollar DrugGlobal Blood Therapeutics: 40% Discount On A Billion-Dollar Drug
seekingalpha.com - November 19 at 10:18 PM
Global Blood Therapeutics (GBT) Surges: Stock Moves 6.9% HigherGlobal Blood Therapeutics (GBT) Surges: Stock Moves 6.9% Higher
finance.yahoo.com - November 13 at 1:18 PM
GBT Announces Participation at the Stifel 2020 Virtual Healthcare ConferenceGBT Announces Participation at the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 13 at 8:18 AM
Analysts Just Slashed Their Global Blood Therapeutics, Inc. (NASDAQ:GBT) EPS NumbersAnalysts Just Slashed Their Global Blood Therapeutics, Inc. (NASDAQ:GBT) EPS Numbers
finance.yahoo.com - November 10 at 8:14 AM
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Here's What You Need To KnowGlobal Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 4:12 PM
Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Heres What You Need To KnowGlobal Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 12:30 PM
Global Blood Therapeutics is Now Oversold (GBT)Global Blood Therapeutics is Now Oversold (GBT)
nasdaq.com - November 6 at 8:11 PM
Mid-Afternoon Market Update: Nasdaq Turns Positive; Global Blood Therapeutics Shares Drop Following Q3 ResultsMid-Afternoon Market Update: Nasdaq Turns Positive; Global Blood Therapeutics Shares Drop Following Q3 Results
benzinga.com - November 6 at 3:10 PM
Global Blood Therapeutics Off on Results Miss, Analyst Rating CutGlobal Blood Therapeutics Off on Results Miss, Analyst Rating Cut
finance.yahoo.com - November 6 at 3:10 PM
Global Blood Therapeutics, Inc. to Host Earnings CallGlobal Blood Therapeutics, Inc. to Host Earnings Call
marketwatch.com - November 6 at 10:02 AM
Global Blood shares tumble 32% after Q3 Oxbryta sales trail estimates; Raymond James cut (GBT) to Market PerformGlobal Blood shares tumble 32% after Q3 Oxbryta sales trail estimates; Raymond James cut (GBT) to Market Perform
seekingalpha.com - November 6 at 10:02 AM
Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q3 2020 Results - Earnings Call TranscriptGlobal Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 10:59 PM
Global Blood Therapeutics (GBT) Reports Q3 Loss, Lags Revenue EstimatesGlobal Blood Therapeutics (GBT) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 5 at 10:59 PM
Global Blood Therapeutics Q3 2020 Earnings PreviewGlobal Blood Therapeutics Q3 2020 Earnings Preview
seekingalpha.com - November 4 at 7:42 PM
Have Insiders Been Buying Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares?Have Insiders Been Buying Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares?
finance.yahoo.com - November 2 at 8:58 AM
GBT to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020GBT to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020
finance.yahoo.com - October 29 at 1:35 PM
Global Blood Therapeutics, Inc.: GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and ThalassemiaGlobal Blood Therapeutics, Inc.: GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
finanznachrichten.de - October 27 at 5:01 PM
GBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) TabletsGBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets
finance.yahoo.com - October 22 at 2:53 PM
Report [2020-2026] Sickle Cell Disease Treatment Market Size, Share, Growth, Trends, Analysis, Competitive Landscape, Forecast by Fortune Business Insights™Report [2020-2026] Sickle Cell Disease Treatment Market Size, Share, Growth, Trends, Analysis, Competitive Landscape, Forecast by Fortune Business Insights™
feeds.benzinga.com - October 13 at 7:15 AM
Global Blood Therapeutics, Inc. (0IVZ.L)Global Blood Therapeutics, Inc. (0IVZ.L)
au.finance.yahoo.com - October 7 at 6:34 PM
Announcing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 102% In The Last Three YearsAnnouncing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 102% In The Last Three Years
finance.yahoo.com - September 17 at 12:23 PM
Hedge Funds Have Never Been This Bullish On Global Blood Therapeutics Inc (GBT)Hedge Funds Have Never Been This Bullish On Global Blood Therapeutics Inc (GBT)
finance.yahoo.com - September 15 at 3:21 AM
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta(R) (voxelotor) in Six Middle Eastern CountriesGBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta(R) (voxelotor) in Six Middle Eastern Countries
marketwatch.com - September 9 at 5:17 AM
Global Blood Therapeutics inks distribution pact with Biopharma-MEA for SCD medGlobal Blood Therapeutics inks distribution pact with Biopharma-MEA for SCD med
seekingalpha.com - September 8 at 6:44 PM
GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern CountriesGBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern Countries
finance.yahoo.com - September 8 at 6:44 PM
Why Is Global Blood (GBT) Down 5.6% Since Last Earnings Report?Why Is Global Blood (GBT) Down 5.6% Since Last Earnings Report?
finance.yahoo.com - September 4 at 1:31 PM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.